| mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
0.22 |
0.1 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
| mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.1 |
| mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
| mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
| mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.1 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.1 |
| mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
| mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.1 |